Considering Whether Sorafenib Is Tolerable In Combination With I-O In HCC

Andrew X. Zhu, MD, PhD Associate Professor, Department of Medicine, Harvard Medical School, Director, Liver Cancer Research, Medicine, Massachusetts General Hospital, Discusses Considering Whether Sor... Author: obr Added: 01/29/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts